Cart summary

You have no items in your shopping cart.

Vatalanib

SKU: orb1225678

Description

A potent, orally available class III receptor tyrosine kinases inhibitor with IC50 of <1 uM for VEGFR, Flt-1, KDR and PDGFRβ; shows no activity against EGFR, FGFR-1, c-Met, and Tie-2, or c-Src, c-Abl, and PKC-α; blocks the VEGF-induced receptor autophosphorylation in CHO cells ectopically expressing the KDR receptor with IC50 of 34 nM; inhibits EGF and PDGF-induced angiogenesis in a growth factor implant model (25-100 mg/kg).Ovarian Cancer Phase 1 Discontinued(In Vitro):Vatalanib also inhibits Flk, c-Kit and PDGFRβ with IC50 of 270 nM, 730 nM and 580 nM, respectively. Vatalanib shows the anti-proliferation effect by inhibiting thymidine incorporation induced by VEGF in HUVECs with and IC50 of 7.1 nM, and dose-dependently suppresses VEGF-induced survival and migration of endothelial cells in the same dose range without cytotoxic or antiproliferative effect on cells that do not express VEGF receptors. A recent study shows that Vatalanib significantly inhibits the growth of hepatocellular carcinoma cells and enhances the IFN/5-FU induced apoptosis by increasing proteins levels of Bax and reduced Bcl-xL and Bcl-2.(In Vivo):Vatalanib induces dose-dependent inhibition of the angiogenic response to VEGF and PDGF in both a growth factor implant model and a tumor cell-driven angiogenesis model after once-daily oral dosing (25-100 mg/kg). In the same dose range, Vatalanib also inhibits the growth and metastasesof several human carcinomas in nude mice without significant effect on circulating blood cells or bone marrow leukocytes.

Images & Validation

Key Properties

CAS Number212141-51-0
MW419.7348
Purity>98% (HPLC)
FormulaC20H17Cl3N4
SMILESClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C4=C2C=CC=C4)C=C1.[H]Cl.[H]Cl
TargetVEGFR
Solubility10 mM in DMSO

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

PTK787 | PTK/ZK | CGP-79787D | CGP-79787 | ZK-222584

Similar Products

  • Vatalanib free base [orb1307623]

    99.52% (May vary between batches)

    212141-54-3

    346.81

    C20H15ClN4

    500 mg, 10 mg, 25 mg, 50 mg, 100 mg, 5 mg
  • Vatalanib succinate [orb1737597]

    212142-18-2

    464.91

    C24H21ClN4O4

    50 mg, 100 mg, 25 mg
  • ZK-261557 [orb1739993]

    300843-21-4

    378.81

    C20H15ClN4O2

    50 mg, 100 mg, 25 mg
  • Vatalanib hydrochloride [orb2565080]

    99.70%

    212141-52-1

    383.27

    C20H16Cl2N4

    50 mg, 10 mg, 5 mg, 100 mg, 1 mg, 200 mg, 25 mg
  • Vatalanib dihydrochloride [orb1300525]

    100.00%

    212141-51-0

    419.73

    C20H15ClN4·2HCl

    50 mg, 100 mg, 200 mg, 10 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Vatalanib (orb1225678)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

500 mg
5 mg
$ 70.00
10 mg
$ 90.00
25 mg
$ 110.00
50 mg
$ 120.00
100 mg
$ 160.00
200 mg
$ 230.00